RABINOWITS, G.; HOMSI, J. .; PARK, S.; KHUSHALANI, N. .; PANELLA, T. .; ELLISON, D.; GENTRY, R.; VENNA, S.; STRASSWIMMER, J.; ZUNIGA, R. .; CHANDRA, S. .; RUIZ, E.; MIGDEN, M.; IBRAHIM, S.; MEHTA, N. .; INOCENCIO, T. .; HE, X.; ZHANG, H.; GILLIS, K. .; POULIOT, J.-F. CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s174, 2023. DOI: 10.25251/skin.7.supp.174. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/1998. Acesso em: 4 jul. 2024.